首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Negative-Ion Chemical Ionization Gas Chromatography–Mass Spectrometry Assay for Enantioselective Measurement of Amphetamines in Oral Fluid: Application to a Controlled Study with MDMA and Driving Under the Influence Cases
【24h】

Negative-Ion Chemical Ionization Gas Chromatography–Mass Spectrometry Assay for Enantioselective Measurement of Amphetamines in Oral Fluid: Application to a Controlled Study with MDMA and Driving Under the Influence Cases

机译:负离子化学电离气相色谱-质谱法测定对苯二酚的对映体选择性测定:在MDMA对照研究中的应用和影响情况下的驾驶

获取原文
           

摘要

Background: Enantioselective analysis of amphetamine (AM), methamphetamine (MA), 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxymethamphetamine (MDMA), and 3,4-methylenedioxyethylamphetamine (MDEA) helps interpret toxicological results. Methods have been described for various matrices, but so far not for oral fluid, a matrix of increasing importance in testing for drugs of abuse, especially in the context of driving under the influence of drugs (DUID).Methods: After dilution with 200 μL carbonate buffer (pH 9), oral fluid samples (10–50 μL) were derivatized with S -heptafluorobutyrylprolyl chloride. The resulting diastereomers were extracted into 100 μL of cyclohexane, separated by gas chromatography (HP-5MS column), and detected by mass spectrometry in the negative-ion chemical ionization mode (GC-NICI-MS). The method was validated and applied to samples from a controlled study with MDMA and from authentic DUID cases.Results: The derivatized AM, MA, MDA, MDMA, and MDEA enantiomers were well separated from each other. The method was linear from 5–250 μg/L per enantiomer of MDA and from 25–1250 μg/L per enantiomer of AM, MA, MDMA, and MDEA. With the exception of MDEA, analytical recoveries, repeatability, and intermediate precision were within required limits. The analyte concentrations and enantiomer ratios in the application samples correlated only weakly with corresponding published plasma data.Conclusions: This sensitive, reliable, and fast GC-NICI-MS assay enantioselectively measures AM, MA, MDA, and MDMA in oral fluid samples. Prediction of plasma concentrations and enantiomer ratios from respective oral fluid data is not possible.
机译:背景:对苯丙胺(AM),甲基苯丙胺(MA),3,4-亚甲基二氧苯丙胺(MDA),3,4-亚甲基二氧甲基苯丙胺(MDMA)和3,4-亚甲基二氧乙基苯丙胺(MDEA)的对映选择性分析有助于解释毒理学结果。已经描述了用于各种基质的方法,但到目前为止还没有针对口服液的描述,这是在测试滥用药物方面越来越重要的基质,尤其是在药物影响下驾驶(DUID)的情况下。方法:用200μL稀释后碳酸盐缓冲液(pH 9),口服液样品(10–50μL)用S-七氟丁酰氯丙烯酰化。将得到的非对映异构体萃取到100μL环己烷中,通过气相色谱法(HP-5MS色谱柱)分离,并通过质谱以负离子化学电离模式(GC-NICI-MS)进行检测。该方法经过验证,可用于来自MDMA对照研究和真实DUID病例的样品。结果:衍生化的AM,MA,MDA,MDMA和MDEA对映异构体彼此良好分离。该方法是线性的,每个MDA对映体为5–250μg/ L,每个AM,MA,MDMA和MDEA对映体为25–1250μg/ L。除MDEA以外,分析物的回收率,重复性和中间精度均在要求的范围内。应用样品中的分析物浓度和对映异构体比率与相应的公开血浆数据之间的相关性很弱。结论:这种灵敏,可靠且快速的GC-NICI-MS分析对映体可选择性地测量口腔液样品中的AM,MA,MDA和MDMA。无法从相应的口腔液数据预测血浆浓度和对映异构体比率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号